Last reviewed · How we verify
Prevention of COVID-19 in individuals 12 years of age and older
Approved treatments
- Comirnaty · Pfizer Inc.
Comirnaty is an mRNA-based vaccine. - BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg · Pfizer
Stimulates the body's immune system to produce antibodies against the SARS-CoV-2 virus. - Tozinameran 12 Years of age and older · Pfizer
- BNT162b7 Monovalent (OMI BA.4/BA.5) · Pfizer
- BNT162b2 Bivalent (WT/OMI BA.1) · Pfizer
- Combination (Bivalent) BNT162b2 and BNT162b2 OMI · Pfizer
- BNT162b7 Bivalent (Original/OMI BA.4/BA.5) · Pfizer
BNT162b7 Bivalent is a mRNA-based vaccine targeting SARS-CoV-2 spike protein. - BNT162b2 vaccine · Vaxxinity, Inc.
Not specified - Investigational COVID-19 Vaccine · BioNTech
- Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) · Pfizer
- BNT162b2 (Omi KP.2) · Pfizer Inc.
- Pfizer-BioNTech COVID-19 mRNA vaccine · Pfizer
mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response - BNT162b2 BA.4/5 bivalent · Pfizer
- BNT162b2 (Omi XBB.1.5)/RIV · Pfizer
- Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose · Pfizer
- Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose · Pfizer
- BNT162b2 (Omi XBB.1.5) · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of COVID-19 in individuals 12 years of age and older patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of COVID-19 in individuals 12 years of age and older treatment landscape brief
- Prevention of COVID-19 in individuals 12 years of age and older treatment updates RSS
Frequently asked questions about Prevention of COVID-19 in individuals 12 years of age and older
What drugs treat Prevention of COVID-19 in individuals 12 years of age and older?
Tracked treatments include Comirnaty, BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg, Tozinameran 12 Years of age and older, BNT162b7 Monovalent (OMI BA.4/BA.5), BNT162b2 Bivalent (WT/OMI BA.1), Combination (Bivalent) BNT162b2 and BNT162b2 OMI, BNT162b7 Bivalent (Original/OMI BA.4/BA.5), BNT162b2 vaccine.
What is the treatment for Prevention of COVID-19 in individuals 12 years of age and older?
Standard treatment for Prevention of COVID-19 in individuals 12 years of age and older includes Comirnaty, BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg, Tozinameran 12 Years of age and older, BNT162b7 Monovalent (OMI BA.4/BA.5), BNT162b2 Bivalent (WT/OMI BA.1). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of COVID-19 in individuals 12 years of age and older patent cliff · Prevention of COVID-19 in individuals 12 years of age and older CI report
- Treatment: Comirnaty · Pfizer Inc.
- Treatment: BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg · Pfizer
- Treatment: Tozinameran 12 Years of age and older · Pfizer
- Treatment: BNT162b7 Monovalent (OMI BA.4/BA.5) · Pfizer
- Treatment: BNT162b2 Bivalent (WT/OMI BA.1) · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing